Medi0382, a Glp-1/glucagon receptor dual agonist, in patients with type 2 diabetes-a multiple-ascending-dose study

Category Primary study
JournalDiabetes
Year 2018
This article has no abstract
Epistemonikos ID: 6390752d621a0d4f5ba3412d72ef21a3ef7d1696
First added on: Feb 09, 2025